BioNTech SE (BNTX) EBT Margin (2018 - 2025)
BioNTech SE (BNTX) reported EBT Margin of 25.06% for Q4 2025, down 5037.0% on a YoY basis from 0.51% in Q4 2024, and down 1641.08% sequentially from 1.63% in Q3 2025.
BioNTech SE (BNTX) EBT Margin (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of EBT Margin data on file, last reported at 25.06% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin fell 5037.0% year-over-year to 25.06%; the trailing twelve-month figure through Dec 2025 stood at 34.95% (down 1039.0% YoY), and the FY2025 full-year result was 36.61%, down 1198.0% from the prior year.
- EBT Margin declined to 25.06% in Q4 2025, from 1.63% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 85.2% in Q4 2021 to a low of 626.11% in Q2 2024.
- A 5-year average of 34.63% and a median of 35.12% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 38031 bps in 2024 and soared 47170 bps in 2025, its largest moves.
- Tracing BNTX's EBT Margin over 5 years: stood at 85.2% in 2021, then retreated by 13 bps to 74.16% in 2022, then plunged by 40 bps to 44.84% in 2023, then plunged by 44 bps to 25.31% in 2024, then sank by 199 bps to 25.06% in 2025.
- Business Quant data shows BNTX's EBT Margin at 25.06% in Q4 2025, 1.63% in Q3 2025, and 154.41% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | -25.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.06% |
| Sep 30, 2025 | 1.63% |
| Jun 30, 2025 | -154.41% |
| Mar 31, 2025 | -243.65% |
| Dec 31, 2024 | 25.31% |
| Sep 30, 2024 | 12.75% |
| Jun 30, 2024 | -626.11% |
| Mar 31, 2024 | -176.87% |
| Dec 31, 2023 | 44.84% |
| Sep 30, 2023 | 25.40% |
| Jun 30, 2023 | -245.80% |
| Mar 31, 2023 | 55.42% |
| Dec 31, 2022 | 74.16% |
| Sep 30, 2022 | 70.61% |
| Jun 30, 2022 | 72.56% |
| Mar 31, 2022 | 78.72% |
| Dec 31, 2021 | 85.20% |
| Sep 30, 2021 | 76.67% |
| Jun 30, 2021 | 75.78% |
| Mar 31, 2021 | 80.17% |